STAT

‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19

"The process is very serious and long," said Massimo Scaccabarozzi of Janssen unit in Milan. For #coronavirus vaccine development, "we have to trust the scientists.”
Medical workers tend to patients at a new intensive care unit for Covid-19 cases at the Casal Palocco hospital near Rome.

The CEO of a global pharmaceutical company’s operations in Italy has advice for anyone expecting a Covid-19 solution anytime soon: Drugs and vaccines take time to create — and to be sure they work safely.

Drug development is a long, long, long process,” Massimo Scaccabarozzi, CEO of Johnson & Johnson’s Janssen unit based in Milan, said Thursday on

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
STAT1 min read
Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
STAT1 min read
STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

Related Books & Audiobooks